Icon beats Street on Q2 earnings, acquires Mapi Group

Drug development provider Icon PLC (Nasdaq: ICLR) saw its stock jump about 6% in value today after announcing second-quarter earnings that beat analysts’ expectations. The Dublin, Ireland–based company, which serves the pharmaceutical, biotechnology and medical device industries, also said it has acquired the Mapi Group, which provides patient-centered health outcomes research and commercialisation. Financial terms of

Preparing for 2026: Transformation ahead for patients, payors, providers and pipelines

Vicki Anastasi/Global Head, Medical Device and Diagnostic Research/ICON plc A decade from now, value-based healthcare, enabled by wearable and electronic health record (EHR) technologies, will be revolutionizing medical device markets. Manufacturers will contend with a changing constellation of customers, from payors to clinicians and patients. It will be important to consider what outcomes they will